CLDI - Calidi Biotherapeutics, Inc.
0.22
-0.011 -5.136%
Share volume: 1,914,128
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.23
-0.01
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-12-2024 | 05-14-2025 | 11-13-2025 | 03-27-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 0.000 | 5.772 M | 5.226 M | 5.062 M | 5.048 M | 4.466 M | |
| Selling general and admin | 0.000 | 3.605 M | 3.073 M | 2.637 M | 2.687 M | 2.108 M | |
| Research and development | 0.000 | 2.167 M | 2.153 M | 2.425 M | 2.361 M | 2.358 M | |
| Total expenses | 6.752 M | 5.772 M | 5.226 M | 5.062 M | 5.048 M | 4.466 M | |
| -14.51% | -9.46% | -3.14% | -0.28% | -11.53% | |||
| Operating income | -6.752 M | -5.772 M | -5.226 M | -5.062 M | -5.048 M | -4.466 M | |
| Ebit | -6.752 M | -5.762 M | -4.838 M | -4.987 M | -5.130 M | -4.263 M | |
| Pretax income | -7.221 M | -5.759 M | -5.070 M | -5.059 M | -5.171 M | -4.061 M | |
| -20.25% | -11.96% | -0.22% | 2.21% | -21.47% | |||
| Income tax | 4.000 K | 8.000 K | -1.000 K | 3.000 K | 10.000 K | -2.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.225 M | -5.767 M | -5.069 M | -5.062 M | -5.181 M | -4.059 M | |
| 20.18% | 12.10% | 0.14% | -2.35% | 21.66% |